Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. | 36,378 | reported | 12 Jun 2026 | tx 1+36,378 |
| Rapport Therapeutics, Inc. | 15,200 | reported | 10 Jun 2026 | tx 5+65,381 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2026 | PURCHASE | ADIAL PHARMACEUTICALS, INC. | 36,378 | 2.75 USD | deriv |
| 10 Jun 2026 | GRANT_AWARD | Rapport Therapeutics, Inc. | 15,200 | 0.00 USD | deriv |
| 11 Sept 2025 | PURCHASE | Rapport Therapeutics, Inc. | 3,500 | 22.60 USD | |
| 17 Jun 2025 | GRANT_AWARD | Rapport Therapeutics, Inc. | 10,925 | 0.00 USD | deriv |
| 12 Mar 2025 | PURCHASE | Rapport Therapeutics, Inc. | 6,000 | 10.21 USD | |
| 07 Nov 2024 | GRANT_AWARD | Rapport Therapeutics, Inc. | 29,756 | 0.00 USD | deriv |